InvestorsHub Logo
Followers 27
Posts 2828
Boards Moderated 0
Alias Born 02/24/2014

Re: Arnie4 post# 51744

Saturday, 02/18/2017 9:47:35 AM

Saturday, February 18, 2017 9:47:35 AM

Post# of 128521
If you had listened to motley fool on the way up then you never would be in the situation you are in right now, up over 200%.

The reality is tweed/bedrocan do not have issues and this whole issue is what allowed canopy to land this deal with such a small premium. Mettrum still has patients, products, hemp line & room to expand.

Canopy hasn't begun to scratch the surface of its quarterly revenues, with Germany opening up and getting very medical licensed as well. If the share price is lower in 2 years than what it is today I would be absolutely stunned.